What Do You Need to Start a Spravato Practice in 2026?
To start a Spravato practice, you need a REMS-certified treatment setting, an enrolled prescriber, trained clinical staff, appropriate monitoring capabilities, a medication acquisition plan, payer readiness, Prior Authorization workflows, and a billing process built before the first treatment.
For most practices, the clinical piece is not what slows the launch. The difficult part is getting REMS, staffing, insurance, medication sourcing, patient scheduling, and reimbursement to work together.
That is where Finnastra helps.
Our Spravato Billing Services are designed to simplify the path from program planning through the first patient, first claim, and ongoing reimbursement.
Step 1: Make Sure Your Practice Is Ready for Spravato
Before completing forms or ordering medication, look at your existing operation.
A Spravato program needs a healthcare setting where patients receive treatment under direct observation and remain under monitoring for at least two hours after each dose.
For an outpatient setting, the current SPRAVATO REMS requirements also include a prescriber onsite during administration and monitoring, trained staff, appropriate monitoring equipment including pulse oximetry, and documented processes for each treatment.
The first questions to answer are practical:
If these answers are unclear, fix the workflow before building volume around it.
Step 2: Complete Spravato REMS Certification
A practice must become certified in the SPRAVATO REMS before treating patients.
For an outpatient clinic, the process starts with designating an Authorized Representative. The representative reviews the required program materials and submits the Outpatient Healthcare Setting Enrollment Form.
Once certified, the practice must maintain REMS requirements throughout treatment.
That includes patient enrollment before outpatient treatment, staff training, direct observation during administration, monitoring for at least two hours, and submission of the required Patient Monitoring Form after treatment.
REMS is not paperwork you complete once and forget.
It becomes part of your daily Spravato workflow.
This is why we prefer building REMS operations and revenue cycle operations together. A clinic that finishes REMS certification without preparing insurance, Prior Authorization, and billing often remains weeks away from being financially ready to treat patients.
Step 3: Build a Staffing Model Around Real Patient Flow
A new Spravato program does not automatically require a large staff.
It needs clearly assigned responsibilities.
Your workflow should identify who handles:
One common mistake is assigning all administrative responsibility to the front desk or medical assistant.
That becomes difficult once patient volume increases.
Prior Authorization alone remains a major administrative burden across U.S. healthcare. The AMA reported in 2026 that physicians complete roughly 40 Prior Authorizations per week, while physicians and staff spend about 13 hours each week managing the process.
For Spravato, where treatment often depends on payer approval before the patient starts, this workload deserves its own process.
Step 4: Decide How You Will Obtain Spravato
Your acquisition model affects both workflow and profitability.
Current REMS enrollment materials recognize two common outpatient pathways. A practice may receive patient-specific medication from a REMS-certified pharmacy, or acquire bulk supply through a REMS-qualified distributor while following applicable federal and state requirements.
For practices considering Buy and Bill, the financial questions matter immediately.
Before placing the first order, understand:
Buy and Bill should never begin with “we will figure out reimbursement later.”
The drug is purchased before the payer pays you. Poor verification or billing turns a promising service line into a cash flow problem surprisingly fast.
When you work with a dedicated Spravato Billing Company like Finnastra, we help connect the acquisition decision with payer reimbursement before volume starts growing.
Step 5: Verify Your Payers Before Marketing the Program Heavily
A REMS-certified clinic is not automatically payer-ready.
This distinction matters.
Before scheduling insured patients, your team should know:
We have seen practices complete the clinical setup first and only later discover that their biggest payer requires a different medication pathway or that a provider is still pending enrollment.
Those problems are easier to solve before the first patient is scheduled.
Step 6: Build Spravato Prior Authorization Before Your First Referral
Prior Authorization is one of the two most important front-end events in Spravato reimbursement. Eligibility is the other.
An authorization workflow should capture clinical requirements before submission, including diagnosis support, treatment history, required assessments, payer-specific criteria, and treatment frequency.
The AMA’s latest data also shows why this deserves attention. Nearly one-third of physicians reported that Prior Authorization requests are often or always denied, while 74% said denials have increased over the previous five years.
A new Spravato practice should not wait for the first denial to build a PA process.
At Finnastra, we verify eligibility first, prepare the authorization around the payer’s actual requirements, track the request, respond to additional information requests, and monitor authorization validity after approval.
Step 7: Make Billing Ready Before the First Treatment
One of the costliest launch mistakes is treating billing as the final step.
Billing decisions should be made before go-live.
Your team needs to know how each payer expects the medication and treatment services reported, what documentation supports the claim, and how authorization data connects with billing.
The workflow should also answer:
As a leading Spravato Billing Services Company, Finnastra ensures these controls are built into the program rather than added after AR starts growing.
Step 8: Launch With a Small, Controlled Patient Flow
You do not need 30 patients to prove your program works.
Start with a workflow your staff controls well.
Follow each patient from eligibility through payment. Watch where delays appear. Look at authorization turnaround, scheduling, documentation, claims, reimbursement, and patient responsibility.
Then scale.
A practice that understands the economics of its first 10 patients is in a far stronger position than one treating 50 patients without knowing why claims are underpaid.
What Does a Successful Spravato Practice Look Like?
A successful program connects clinical care and revenue operations.
Patients move through a predictable process:
Eligibility Verification → Prior Authorization → Patient Enrollment → Medication Coordination → Treatment → Documentation → Billing → Payment → Reauthorization
When ownership is clear at every stage, the practice spends less time fixing problems later.
How Finnastra Helps Practices Launch Spravato
We work with practices before and after launch.
Instead of waiting for denied claims to appear, we help establish the infrastructure that supports reimbursement from the beginning.
For our clients, we:
That is the difference between hiring someone to submit claims and working with a specialty-focused revenue cycle partner.
What Should You Look for in a Spravato Billing Partner?
Practices searching for a Top Spravato Billing Company in U.S. should look beyond the percentage charged for billing.
Ask whether the company understands the entire treatment model.
The Best Spravato Billing Company in U.S. for your practice should help prevent revenue problems, not simply work them after they occur.
This is the model Finnastra follows.
Frequently Asked Questions
Start by reviewing your clinical setting, provider readiness, staffing, and REMS requirements. Build the operational and payer strategy alongside REMS certification rather than waiting until certification is complete.
Yes. SPRAVATO is available through a restricted REMS program and treatment must occur in a certified healthcare setting under the required monitoring conditions.
The SPRAVATO REMS requires monitoring by a healthcare provider for at least two hours after administration, with discharge based on the provider’s assessment.
The right model depends on payer mix, acquisition cost, cash flow, expected volume, and reimbursement. Buy and Bill offers greater financial control for many practices, but the economics should be reviewed before medication is purchased.
Before the first treatment. Eligibility, Prior Authorization, documentation, coding, claim submission, and AR workflows should already have defined ownership when the first patient begins therapy.
Yes. Finnastra supports practices from REMS enrollment and payer readiness through Prior Authorization, eligibility verification, billing, denials, AR, and ongoing reimbursement management.
Ready to Start Your Spravato Practice?
A Spravato launch should not feel like separate projects involving REMS, insurance, medication, and billing.
They are parts of the same program.
When you work with a dedicated Spravato Billing Company like Finnastra, we help connect those pieces from the beginning so your clinic reaches treatment readiness and reimbursement readiness together.
If you are planning a Spravato Practice Setup in 2026, Finnastra is ready to support the program from setup through revenue generation.
Learn more about Finnastra’s Spravato Billing Services at: https://finnastra.com/spravato-billing/
